Sixty years ago, Dr. George Koepf had a vision of an Institute that would specialize in basic medical research (related to endocrine problems, diabetes, thyroid problems, and obesity amongst others). His vision became a reality in 1956 when his patient, Helen Woodward Rivas, generously donated funds to start the Medical Foundation of Buffalo (MFB).

We’ve come a long way since 1956. In our new state-of-the-art facility, under the Hauptman-Woodward Medical Research Institute name, we work at the cutting edge (of our area) of science, with the most advanced X-ray source in the world, and we’ve helped crystallize thousands of proteins resulting in profound fundamental structural knowledge. We have highly qualified investigators supported by grants from the National Institutes of Health and the National Science Foundation. We are well known in the national and international science community.

During this anniversary year, we invite you to visit our Institute, to see what we do, and to help spread the word and help us grow. Biotech in Buffalo is blooming. The Institute was one of the initial seeds and we will be part of the growth. Help us celebrate another 60 years of research by supporting a new generation of scientists and continuing our impact in Buffalo and beyond. (We innovate, discover, educate –cures really do begin here!)

Edward Snell, PhD
HWI President and CEO
HWI is celebrating its 60th anniversary this year. It has been 60 years since Helen Woodward Rivas gave her founding gift of $3 million in 1956 to support the leading edge research of Dr. George Koepf (the equivalent of a $26 million gift in today’s economy). I am pleased to see the impact that HWI has had over this time period and how well poised it is to have significant impact in the future. It is my hope she would feel the same. I actively participate in this promising future as a friend to the Institute and it is my hope that you will continue to do the same. The Institute's scientific team is talented, dedicated and inspires us daily.

Best regards, Judy Feldman, HWI Board Chair

HWI Board of Directors 2017-2018

Christina Arthurs, Esq.
Lippes Mathias Wexler & Friedman

Frederick G. Attea, Esq.
Partner, Phillips Lytle LLP

E. J. Burke
Co-President, Key Community Bank

Emily Constantine Doren
Owner, Lace & Day

William J. Constantine
Managing Director, 19/19 Investment Counsel

Sasidhar (Sash) Eranki
VP & Corporate Officer, Moog, Inc.

Judith A. Feldman
BIA Consulting Services

Daniel T. Gewirth, PhD
Principal Research Scientist, Hauptman-Woodward Medical Research Institute

Venu Govindaraju, PhD
VP Research for Research & Economic Development, University at Buffalo
SUNY Dist. Professor School of Engineering & Applied Sciences

Jane F. Griffin, PhD
Emeritus Principal Research Scientist, Hauptman-Woodward Medical Reseacrh Institute

Michelle Heffernan, Esq.

John G. Horn, Esq.
Partner, Harter Secrest & Emery LLP

Charles E. Lannon
Strategic Advisory, Inc.

Peter McCauley
President, McGard

Thomas McMahon
President & CEO, CUBRC

Richard Mueller
Vice President, Commercial Real Estate
M & T Bank

Philip D. Nobel
Vice President, Harry R. Defler Corp.

James Obletz
Delaware North Companies

Kunle Odunsi MD
Deputy Director Cancer Center
Chair. OB/GYN Dept
Exec Dir, Center for Immunotherapy
Roswell Park Cancer Institute

Anthony P. Pandolfi, CFP, CLU
UBS Financial Service-The Wells Group

Edward H. Snell, PhD
President and CEO
Hauptman-Woodward Medical Research Institute

Franca Trincia, CPA
CFO, Olmsted Center for Sight

Emeritus Directors

Stuart H. Angert

Richard Aubrecht, PhD

Thomas R. Beecher, Jr.

Norbert A. Bennett, CPA

James R. Biltekoff

Constance S. Constantine

Christopher T. Greene

L. Nelson Hopkins, III, MD

James R. Kanski, MD

Charles A. Martin, Jr.

Lewis D. McCauley

Elizabeth S. Mitchell

Donald F. Newman

Peter T. Ostrow, MD, PhD

Joseph A. Voelkl

Pamela Vogt

Albert J. Wright, III
Our team's mission is to strive to provide the highest level of support to the research groups at the Institute. Our commitment to furthering their work serves the well and our community. Cures begin here through teamwork.

Lisa Keefe, PhD
Vice President for Advancing Therapeutics
Director of IMCA-CAT

Anne Kent
Chief Financial Officer

Edward Snell, PhD
President & CEO

Jill Szczesek
Chief Operating Officer
The Scientific Governance Council consists members of HWI's scientific staff and are elected by their peers to three-year terms. The Council is involved in all major decisions that affect the future of the Institute. Their primary duties focus on scientific matters such as fostering new and existing research programs, recruiting and mentoring young scientists, and reviewing scientific projects and grant requests. In addition, they are responsible for the maintenance of the physical laboratories and serve as a sounding board and advisory council for the executive and support departments. The Governance Council is also used as a mechanism to identify and groom future leaders while establishing a strong, committed leadership team.

Daniel T. Gewirth, Chair